Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: AIRTIGHT PACKAGE FOR OVERSEA SHIPMENT
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000KGS MONTHLY
Port: BEIJING,SHANGHAI,QINGDAO
Payment Type: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
3-Methyl-6-nitro-1H-indazole is an important intermediate of the patent drug , which is developed by GlaxoSmithKline to interfere with the survival and growth of stubborn tumors. A new type of oral angiogenesis inhibitor of new angiogenesis, which targets the vascular endothelial growth factor receptor (VEGFR), and acts by inhibiting the formation of new blood vessels supplying tumors.
PRODUCT 3-Methyl-6-nitroindazole
CAS 6494-19-5
MF C8H7N3O2
MW 177.16
Product Categories : API Intermediates > Pazopanib HCL Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.